257 related articles for article (PubMed ID: 2433851)
1. [Current aspects of tumor immunology].
Donat H; Schiller S
Zentralbl Gynakol; 1986; 108(19):1153-63. PubMed ID: 2433851
[TBL] [Abstract][Full Text] [Related]
2. [Immunotherapy of malignant growths (author's transl)].
Gericke D
Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():350-7. PubMed ID: 88728
[TBL] [Abstract][Full Text] [Related]
3. Antigens, enzymes and hormones. Their roles as tumor markers in gynecologic neoplasia.
Fenoglio CM
Diagn Gynecol Obstet; 1980; 2(1):33-42. PubMed ID: 6162629
[TBL] [Abstract][Full Text] [Related]
4. [Significance of the contemporary determination of tumor associated antigens in patients with various types of neoplasms of the genital tract].
Sacco F; Benedetti Panici P; Villani L; Di Roberto P; Barile G; Iacobelli S
Minerva Ginecol; 1978 Oct; 30(10):811-6. PubMed ID: 82920
[No Abstract] [Full Text] [Related]
5. The immunological aspects of malignant disease.
Oliver RT
Practitioner; 1975 Apr; 214(1282):511-521. PubMed ID: 49889
[No Abstract] [Full Text] [Related]
6. [Radioimmunoassays in oncology].
Dressler J
Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
[TBL] [Abstract][Full Text] [Related]
7. Murine polyomavirus tumour specific transplantation antigens and viral persistence in relation to the immune response, and tumour development.
Ramqvist T; Dalianis T
Semin Cancer Biol; 2009 Aug; 19(4):236-43. PubMed ID: 19505651
[TBL] [Abstract][Full Text] [Related]
8. Immunologic tests in diagnosis of cancer.
Herberman RB
Am J Clin Pathol; 1977 Nov; 68(5 Suppl):688-98. PubMed ID: 72502
[TBL] [Abstract][Full Text] [Related]
9. [Radioimmunological determination of the carcinoembryonic antigen, alpha-fetoprotein and other tumor antigens in oncological patients before and after radiation therapy].
Dobrovol'skiĭ NM; Matveenko EG; Firsova PP; Gapaniuk ON; Smirnova IA
Med Radiol (Mosk); 1979 Oct; 24(10):43-7. PubMed ID: 91939
[No Abstract] [Full Text] [Related]
10. [Tumor markers--current problems in clinical application].
Yachi A
Rinsho Byori; 1982 May; 30(5):488-91. PubMed ID: 6182314
[No Abstract] [Full Text] [Related]
11. Tumour immunotherapy: the adjuvant treatment of the 21st century?
Bremers AJ; Kuppen PJ; Parmiani G
Eur J Surg Oncol; 2000 Jun; 26(4):418-24. PubMed ID: 10873365
[TBL] [Abstract][Full Text] [Related]
12. [The immunologic tumor diagnosis].
Müller M
Z Gesamte Inn Med; 1976 Oct; 31(19):782-90. PubMed ID: 65843
[TBL] [Abstract][Full Text] [Related]
13. [T antigen and CEA; comparison between 2 tumor markers in breast cancer and malignant gynecologic neoplasms].
Scheiffarth OF
Arch Gynecol; 1979 Jul; 228(1-4):659-60. PubMed ID: 485546
[No Abstract] [Full Text] [Related]
14. Tumor immunity and immunotherapy.
Boura P; Kountouras J; Lygidakis NJ
Hepatogastroenterology; 2001; 48(40):1040-4. PubMed ID: 11490795
[TBL] [Abstract][Full Text] [Related]
15. Clinical use of gynaecologic tumour markers.
Halila H; Alfthan H; Stenman UH
Ann Chir Gynaecol; 1989; 78(1):65-70. PubMed ID: 2547331
[TBL] [Abstract][Full Text] [Related]
16. Overview of oncofetal antigens in cancer.
Wepsic HT
Ann Clin Lab Sci; 1983; 13(4):261-6. PubMed ID: 6194734
[TBL] [Abstract][Full Text] [Related]
17. Current aspects of tumor immunology. Preface and introduction.
Weiss DW
Isr J Med Sci; 1973 Mar; 9(3):205-16. PubMed ID: 4575649
[No Abstract] [Full Text] [Related]
18. An introduction to tumour immunology.
James K
Arch Immunol Ther Exp (Warsz); 1983; 31(6):795-808. PubMed ID: 6611141
[TBL] [Abstract][Full Text] [Related]
19. [Tumor-associated antigens. Onco-fetal antigens: significance and clinical use].
Cammilluzzi E; Crupi M; Foggi CM
Chir Ital; 1980 Apr; 32(2):318-36. PubMed ID: 6165494
[No Abstract] [Full Text] [Related]
20. Tolerance and cancer: mechanisms of tumor evasion and strategies for breaking tolerance.
Mapara MY; Sykes M
J Clin Oncol; 2004 Mar; 22(6):1136-51. PubMed ID: 15020616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
